Publications
Hull RL, Peters MJ, Potter-Perigo S, Chan CK, Wight TN, Kinsella MG: Overall degree of sulfation of heparan sulfate from pancreatic islet β-TC3 cells determines fibril formation but not binding to the amyloidogenic peptide islet amyloid polypeptide. Journal of Biological Chemistry, 287:37154-37164, 2012. PMC3481315. Supported by CFAC
Hull RL, Johnson P, Braun K, Day AJ, Wight TN: Hyaluronan and hyaluronan binding proteins are normal components of mouse pancreatic islets and are differentially expressed by islet endocrine cell types. Journal of Histochemistry and Cytochemistry, 60:749-760, 2012 . PMC in process.
Blevins JE, Moralejo DH, Wolden-Hanson TH, Thatcher BS, Ho JM, Kaiyala KJ, Matsumoto K. Alterations in activity and energy expenditure contribute to lean phenotype in Fischer 344 rats lacking the cholecystokinin-1 receptor gene. Am J Physiol Regul Integr Comp Physiol. [Epub ahead of print] 2012 Oct 31
Monteiro-Soares M, Boyko E, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: a systemic review. Diabetes Metab Res Rev. [Epub ahead of print] 2012.
Wander PL, Boyko EJ, Leonetti DL, McNeely MJ, Fujimoto WY, Kahn SE. Change in visceral adiposity independently predicts a greater risk for developing type 2 diabetes over 10 years in Japanese Americans. Diabetes Care. [Epub ahead of print] 2012.
Mehta S, Melhorn SJ, Smeraglio A, Tyagi V, Grabowski T, Schwartz MW, Schur EA. Regional brain response to visual food cues is a marker of satiety that predicts food choice. Am J Clin Nutr. In press, 2012.
Schwartz, MW. An inconvenient truth about obesity. Mol Med. In press, 2012.
Sarruf DA, Bonner-Weir S and Schwartz MW. New clues to bariatric surgery's benefits. Nat Med 18:860-861, 2012.
Smits MM, Boyko EJ, Utzschneider KM, Leonetti DL, McNeely MJ, Suvag S, Wright LA, Fujimoto WY, Kahn SE. Arm length is associated with type 2 diabetes mellitus in Japanese-Americans. Diabetologia 55:1679-1684, 2012.
Marina AL, Utzschneider KM, Wright LA, Montgomery BK, Marcovina SM, Kahn SE. Colesevelam improves oral but not intravenous glucose tolerance by a mechanism independent of insulin sensitivity and β-cell function. Diabetes Care 35:1119-1125, 2012.
Pages
